Medtronic Owes $106.5 Million on Colibri Heart Valve Patent (1)

Medtronic Plc’s CoreValve unit must pay Colibri Heart Valve LLC $106.5 million as a federal jury in California found three of its Evolut-branded systems induce doctors to infringe a patent for a device used to replace heart valves less invasively than open-heart surgery.

Jurors also rejected Medtronic CoreValve LLC‘s arguments that the patent should be canceled, according to a verdict returned Wednesday and docketed Thursday in the US District Court for the Central District of California.

“Medtronic strongly disagrees with the ruling and will continue to vigorously defend against these allegations at the appellate level,” a company spokesperson said ...